- 25371 Commercentre Dr, Lake Forest, CA 92630
- Patients Results
Comprehensive DNA and RNA profiling for solid tumors and hematologic malignancies, including liquid biopsy that integrates cell free DNA and cell free RNA to reveal clinically meaningful tumor signatures.
Genomic Testing Cooperative is a cooperative model clinical laboratory designed to expand access to advanced cancer genomics without compromising clinical rigor. We combine next generation sequencing with informatics and AI driven interpretation to translate complex molecular data into reports that are practical for real world decision making, whether the case is a solid tumor, a hematologic malignancy, or a liquid biopsy scenario where tissue is limited.
Dr. Albitar is a board certified pathologist with deep expertise across hematopathology and molecular diagnostics, with extensive executive leadership experience in large scale laboratory environments and a long track record in scientific publishing and innovation.
Dr. Agersborg brings decades of experience spanning anatomic pathology, hematopathology, molecular pathology and laboratory administration, supporting clinical quality and interpretive oversight across complex oncology testing.
Our approach is built around integrated DNA and RNA profiling and a streamlined menu that covers both heme and solid tumors, so teams can get comprehensive answers up front. The goal is speed with substance: actionable insights delivered in a clinically relevant format, backed by a cooperative mindset that prioritizes collaboration, operational efficiency, and consistent quality.
GTC focuses on comprehensive tumor profiling using next generation sequencing across solid tumors and hematologic malignancies, with options that include liquid biopsy via Liquid Trace.
Liquid Trace is presented as a cfDNA and cfRNA based assay designed to expand what can be learned from blood based testing, with gene coverage described on GTC materials as more than 300 cfDNA genes and more than 1600 cfRNA genes.
Ordering guidance is provided through GTC’s ‘How to Order’ pathway, and Client Services is positioned as the direct support channel for questions and kit coordination.
GTC’s own published positioning emphasizes accelerated turnaround compared with typical industry ranges, with multiple site pages referencing delivery windows around 5 to 10 days and specific messaging such as about 7 days for DNA and about 10 days for RNA in certain workflows.
For some liquid biopsy workflows, GTC notes RNA stability windows and shipping urgency, which is why they emphasize prompt shipment and kit based handling instructions.
GTC publishes separate billing contact details and office hours for billing support, which can be placed here to reduce friction for patients and clients.
